Showing results (71-80 of 176) with videos related to

Sort By:
Pageof 18
Therapeutic Innovation & Regulatory Science|July 19, 2021
A New Paradigm for Safety Data Signal Detection and Evaluation Using Open-Source Software Created by an Interdisciplinary Working GroupJames Buchanan, Mengchun Li, Xiao Ni, et al.
Plos One|January 6, 2011
Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illnessJames Buchanan, Borislava Mihaylova, Alastair Gray, et al.
BMC Pregnancy and Childbirth|August 10, 2016
Women's birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literatureJennifer Hollowell, Yangmei Li, Reem Malouf, et al.
Transfusion|January 31, 2018
Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health ServiceElizabeth A Stokes, Sarah Wordsworth, Julie Staves, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 31, 2019
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United KingdomKatharina Schwarze, James Buchanan, Jilles M Fermont, et al.
Obesity Surgery|October 29, 2018
Multi-Centre Micro-Costing of Roux-En-Y Gastric Bypass, Sleeve Gastrectomy and Adjustable Gastric Banding Procedures for the Treatment of Severe, Complex ObesityBrett Doble, Richard Welbourn, Nicholas Carter, et al.
European Heart Journal|March 20, 2010
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness modelSarah Wordsworth, José Leal, Edward Blair, et al.
Health and Quality of Life Outcomes|September 22, 2018
Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation studyBrett Doble, Maria Pufulete, Jessica M Harris, et al.
Orphanet Journal of Rare Diseases|April 12, 2023
Retrospective file review shows limited genetic services fails most patients - an argument for the implementation of exome sequencing as a first-tier test in resource-constraint settingsEmma K Wiener, James Buchanan, Amanda Krause, et al.
Pharmacoeconomics - Open|December 16, 2018
Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UKYaling Yang, Lucy Abel, James Buchanan, et al.
Pageof 18